PDK2 promotes multiple tumor drug resistance by inhibiting tumor mitochondrial function (Kitamura et al. 2021; Liang et al. 2020) and negatively regulating macrophage polarization(Li et al. 2017). Here, PDK2 is linked to neoplasm.